References
- 1. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031-41. DOI: 10.1152/ajpheart.01058.200410.1152/ajpheart.01058.200415653761
- 2. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30(3):400-18. DOI: 10.1038/sj.ijo.0803177 10.1038/sj.ijo.080317716302012
- 3. Powers SK, DeRuisseau KC, Quindry J, Hamilton KL. Dietary antioxidants and exercise. J Sports Sci. 2004;22(1):81-94. DOI: 10.1080/026404103100014056310.1080/026404103100014056314971435
- 4. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol. 2003;23(3):365-7. DOI: 10.1161/01.ATV.0000063608.43095.E210.1161/01.ATV.0000063608.43095.E212639823
- 5. Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord. 2001;25(3):378-88. DOI: 10.1038/sj.ijo.080153610.1038/sj.ijo.080153611319636
- 6. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem. 2004;50(11):2190-3. DOI: 10.1373/clinchem.2004.03437110.1373/clinchem.2004.03437115502098
- 7. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, et al. Association between ischemia- modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 2009;42(7-8):666-71. DOI: 10.1016/j.clinbiochem.2009.01.01010.1016/j.clinbiochem.2009.01.01019318029
- 8. Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43(4- 5):450-4. DOI: 10.1016/j.clinbiochem.2009.11.01810.1016/j.clinbiochem.2009.11.01819968982
- 9. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia- modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers. 2008;24(6):311-7. DOI: 10.1155/2008/78431310.1155/2008/784313385061518688079
- 10. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab. 2010;95(2):586-91. DOI: 10.1210/jc.2009-159210.1210/jc.2009-1592284086820016051
- 11. Bhagavan NV, Ha JS, Park JH, Honda SA, Rios CN, Sugiyama C, et al. Utility of serum Fatty Acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem. 2009;55(8):1588-90. DOI: 10.1373/clinchem.2008.12331510.1373/clinchem.2008.123315
- 12. Aslan D, Apple FS. Ischemia modified albumin: clinical and analytical update, Lab Med. 2004;35(1):44-47. DOI: 10.1309/XXYETJN8YM9HBD9C 10.1309/XXYETJN8YM9HBD9C
- 13. Senes M, Kazan N, Coskun O, Zengi O, Inan L, Yucel D. Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem. 2007;44(Pt 1):43-7. DOI: 10.1258/00045630777959605710.1258/000456307779596057
- 14. Yesilbursa D, Serdar Z, Serdar A, Sarac M, Coskun S, Jale C. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes (Lond). 2005;29(1):142-5. DOI: 10.1038/sj.ijo.080279410.1038/sj.ijo.0802794
- 15. Prázný M, Skrha J, Hilgertová J. Plasma malondialdehyde and obesity: is there a relationship? Clin Chem Lab Med. 1999;37(11-12):1129-30. DOI: 10.1515/CCLM.1999.16410.1515/CCLM.1999.164
- 16. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab. 2001;86(1):355-62.
- 17. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627-31. DOI: 10.1016/S0009-9120(02)00363-610.1016/S0009-9120(02)00363-6
- 18. World Health Organisation. Obesity: Preventing and managing the Global Epidemic. Report of a WHO Consultation on Obesity. ISBN 9241208945, 2000; 3-5.
- 19. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112-9. DOI: 10.1016/j.clinbiochem. 2003.10.014
- 20. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998;44(6 Pt 1):1309-15.10.1093/clinchem/44.6.1309
- 21. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.00810.1016/j.clinbiochem.2005.08.008
- 22. Verit FF, Verit A, Kocyigit A, Ciftci H, Celik H, Koksal M. No increase in sperm DNA damage and seminal oxidative stress in patients with idiopathic infertility. Arch Gynecol Obstet. 2006;274(6):339-44. DOI: 10.1007/s00404-006-0172-910.1007/s00404-006-0172-9
- 23. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003;133(41-42):563-6.10.4414/smw.2003.10397
- 24. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt- albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19(4):311-5. DOI: 10.1016/S0736-4679(00)00255-910.1016/S0736-4679(00)00255-9
- 25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. DOI: 10.1007/BF0028088310.1007/BF002808833899825
- 26. Ozcelik O, Ozkan Y, Karatas F, Kelestimur H. Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects. Tohoku J Exp Med. 2005;206(4):313-8. DOI: 10.1620/tjem.206.31310.1620/tjem.206.31315997202
- 27. Kurban S, Mehmetoglu I, Yerlikaya HF, Gonen S, Erdem S. Effect of chronic regular exercise on serum ischemia- modified albumin levels and oxidative stress in type 2 diabetes mellitus. Endocr Res. 2011;36(3):116-23. DOI: 10.3109/07435800.2011.56623610.3109/07435800.2011.56623621736494
- 28. Brown LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity (Silver Spring). 2009;17(3):460-6. DOI: 10.1038/oby.2008.59010.1038/oby.2008.59019131942
- 29. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP, Tonello R, et al. Ischemia modified albumin as an oxidative stress biomarker in obesity. Clin Biochem. 2011;44(4):345-7. DOI: 10.1016/j.clinbiochem.2010.12.00110.1016/j.clinbiochem.2010.12.00121159315
- 30. Bourdon E, Loreau N, Lagrost L, Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic Res. 2005;39(1):15-20. DOI: 10.1080/1071576040002493510.1080/1071576040002493515875807
- 31. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000;35(4):1009-15. DOI: 10.1161/01.HYP.35.4.100910.1161/01.HYP.35.4.100910775577
- 32. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med. 2004;42(4):455-61. DOI: 10.1515/CCLM.2004.07910.1515/CCLM.2004.07915147158
- 33. Piva SJ1, Tatsch E, De Carvalho JA, Bochi GV, Kober H, Duarte T, Duarte MM, da Cruz IB, Moretto MB, Moresco RN. Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index. Inflammation. 2013;36(1):226-31. DOI: 10.1007/s10753-012-9538-210.1007/s10753-012-9538-222961567